Joshua Hare, Chief Scientific Officer at Longeveron Inc. (LGVN), bought 297,872 shares at $2.35 ($700K) on 2024-04-11, disclosed to the SEC on 2024-04-12.
Open-market purchase of $700k LGVN by Chief Scientific Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.35 | 106,383 | $250K | 35.7% |
| 2 | $2.35 | 106,383 | $250K | 35.7% |
| 3 | $2.35 | 42,553 | $100K | 14.3% |
| 4 | $2.35 | 42,553 | $100K | 14.3% |
| Total | $2.35 avg | 297,872 | $700K | 100% |
| Filing → |
| LGVN | SELL | 2022-12-05 | $75K | — | Filing → |
| LGVN | SELL | 2022-10-18 | $361K | — | Filing → |
| LGVN | SELL | 2022-04-20 | $200K | — | Filing → |